Clinical Trials Directory

Trials / Completed

CompletedNCT02261025

The Effect Of Aspirin On Survival in in Patients Undergoing Chronic Hemodialysis

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
410 (actual)
Sponsor
Shanghai Jiao Tong University School of Medicine · Academic / Other
Sex
All
Age
18 Years – 85 Years
Healthy volunteers
Not accepted

Summary

The aim of present study is to examine the effect of low-dose aspirin on the incidence of cardiovascular events and mortality in patients undergoing chronic hemodialysis.

Detailed description

This study prospectively evaluate the impacts of low dose aspirin on survival and cardio-cerebral vascular events in a large cohort of Chinese patients undergoing chronic hemodialysis. Between January 2008, consecutive patients with hemodialysis with aspirin were enrolled.We examine the association of aspirin with all-cause mortality in patients matched by propensity scores using the Kaplan-Meier method and Cox models in "intention-to-treat" analyses.The secondary endpoint was rate of cardio-cerebral events.

Conditions

Interventions

TypeNameDescription
DRUGacetylsalicylic acid75-100mg,per day

Timeline

Start date
2008-01-01
Primary completion
2014-09-01
Completion
2014-09-01
First posted
2014-10-09
Last updated
2014-10-23

Source: ClinicalTrials.gov record NCT02261025. Inclusion in this directory is not an endorsement.